Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia
January 20, 2021
WAYNE, Pa.— January 20, 2021—Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology...
Read MoreResearch Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting
November 19, 2020
New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia
Read MoreTeleflex Interventional Urology Expands Portfolio with Introduction of the UroLift® Advanced Tissue Control (ATC)™ System
October 28, 2020
WAYNE, Pa., – October 28 2020 – Teleflex Incorporated (NYSE: TFX) today announced the expansion of its UroLift® System portfolio with the...
Read MoreTeleflex Announces 200,000 Patients Treated with UroLift System for Enlarged Prostate
July 30, 2020
Minimally Invasive, Same-Day Outpatient Procedure Provides Rapid Symptom Relief and Recovery
Read MoreTeleflex Announces Positive Data Emphasizing the Effectiveness of the UroLift® System Treatment for Enlarged Prostate Across Broad Patient Populations
July 21, 2020
Data Presented at European Association of Urology Highlights Safety and Versatility of the Minimally Invasive UroLift System in a Real-World Setting
Read MoreTeleflex Announces Publication of Early Patient Experience Data Highlighting the UroLift® System as a Superior Treatment to Rezum™ Steam Injection in Patients with Enlarged Prostate
June 22, 2020
Data Shows Minimally Invasive Treatment Provides Rapid Symptom Relief, Allowing Men to Return to Daily Activities Quickly
Read MoreIn Honor of Men’s Health Month, Teleflex Announces Virtual Community Health Talk for Men with Benign Prostatic Hyperplasia
June 8, 2020
Free, Online Presentation to Address Symptoms of Enlarged Prostate, Treatment Options and Tips for Managing Condition During Pandemic WAYNE, PA.—...
Read MoreTeleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*
May 18, 2020
Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the...
Read MoreTeleflex Celebrates 175,000 Patients Treated with the UroLift® System
March 11, 2020
Minimally Invasive Treatment for Enlarged Prostate Provides Rapid Relief1 and Durable Results2 WAYNE, Pa.— March 11, 2020—Teleflex Incorporated...
Read MoreTeleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
January 7, 2020
Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief.
Read More
